Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Abstract:
Impaired epithelial barrier function plays a crucial role inthe pathogenesis of inflammatory bowel disease. Elevated levelsof the pro-inflammatory cytokine, interferon- (IFN), are believedto be prominently involved in the pathogenesis of Crohn disease.Treatment of T84 intestinal epithelial cells with IFN severelyimpairs their barrier properties measured as transepithelialelectrical resistance (TER) or permeability and reduces theexpression of tight junction proteins such as occludin and zonulaoccludens-1 (ZO-1). However, little is known about the signalingevents that are involved. The cellular energy sensor, AMP-activatedprotein kinase (AMPK), is activated in response to cellularstress, as occurs during inflammation. The aim of this studywas to investigate a possible role for AMPK in mediating IFN-inducedeffects on the intestinal epithelial barrier. We found thatIFN activates AMPK by phosphorylation, independent of intracellularenergy levels. Inhibition of AMPK prevents, at least in part,the IFN-induced decrease in TER. Furthermore, AMPK knockdownprevented the increased epithelial permeability, the decreasedTER, and the decrease in occludin and ZO-1 caused by IFN treatmentof T84 cells. However, AMPK activity alone was not sufficientto cause alterations in epithelial barrier function. These datashow a novel role for AMPK, in concert with other signals inducedby IFN, in mediating reduced epithelial barrier function ina cell model of chronic intestinal inflammation. These findingsmay implicate AMPK in the pathogenesis of chronic intestinalinflammatory conditions, such as inflammatory bowel disease.
Received for publication July 20, 2009.
Revision received August 3, 2009.
1 To whom correspondence should be addressed: Division of Gastroenterology, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0063. Tel.: 858-534-2794; Fax: 858-534-3338; E-mail: dmccole{at}ucsd.edu.
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Elizabeth M. Adler (13 October 2009) Sci. Signal.2 (92), ec332.
[DOI: 10.1126/scisignal.292ec332] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Interferon-{gamma} Activates Transglutaminase 2 via a Phosphatidylinositol-3-Kinase-Dependent Pathway: Implications for Celiac Sprue Therapy.
T. R. DiRaimondo, C. Klock, and C. Khosla (2012)
J. Pharmacol. Exp. Ther.
341, 104-114
|Abstract »|Full Text »|PDF »
Interferon-{gamma} Alters Downstream Signaling Originating from Epidermal Growth Factor Receptor in Intestinal Epithelial Cells: FUNCTIONAL CONSEQUENCES FOR ION TRANSPORT.
G. Paul, R. R. Marchelletta, D. F. McCole, and K. E. Barrett (2012)
J. Biol. Chem.
287, 2144-2155
|Abstract »|Full Text »|PDF »
Transforming Growth Factor-{beta}, a Whey Protein Component, Strengthens the Intestinal Barrier by Upregulating Claudin-4 in HT-29/B6 Cells.
N. A. Hering, S. Andres, A. Fromm, E. A. van Tol, M. Amasheh, J. Mankertz, M. Fromm, and J. D. Schulzke (2011)
J. Nutr.
141, 783-789
|Abstract »|Full Text »|PDF »
AMP-Activated Protein Kinase Inhibits IGF-I Signaling and Protein Synthesis in Vascular Smooth Muscle Cells via Stimulation of Insulin Receptor Substrate 1 S794 and Tuberous Sclerosis 2 S1345 Phosphorylation.
Epithelial Myosin Light Chain Kinase Activation Induces Mucosal Interleukin-13 Expression to Alter Tight Junction Ion Selectivity.
C. R. Weber, D. R. Raleigh, L. Su, L. Shen, E. A. Sullivan, Y. Wang, and J. R. Turner (2010)
J. Biol. Chem.
285, 12037-12046
|Abstract »|Full Text »|PDF »